rs73658916

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_006059.4(LAMC3):​c.2039C>T​(p.Thr680Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00211 in 1,614,048 control chromosomes in the GnomAD database, including 30 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Synonymous variant affecting the same amino acid position (i.e. T680T) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.0078 ( 18 hom., cov: 33)
Exomes 𝑓: 0.0015 ( 12 hom. )

Consequence

LAMC3
NM_006059.4 missense

Scores

17

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: -2.90

Publications

5 publications found
Variant links:
Genes affected
LAMC3 (HGNC:6494): (laminin subunit gamma 3) Laminins, a family of extracellular matrix glycoproteins, are the major noncollagenous constituent of basement membranes. They have been implicated in a wide variety of biological processes including cell adhesion, differentiation, migration, signaling, neurite outgrowth and metastasis. Laminins are composed of 3 non identical chains: laminin alpha, beta and gamma (formerly A, B1, and B2, respectively) and they form a cruciform structure consisting of 3 short arms, each formed by a different chain, and a long arm composed of all 3 chains. Each laminin chain is a multidomain protein encoded by a distinct gene. Several isoforms of each chain have been described. Different alpha, beta and gamma chain isomers combine to give rise to different heterotrimeric laminin isoforms which are designated by Arabic numerals in the order of their discovery, i.e. alpha1beta1gamma1 heterotrimer is laminin 1. The biological functions of the different chains and trimer molecules are largely unknown, but some of the chains have been shown to differ with respect to their tissue distribution, presumably reflecting diverse functions in vivo. This gene encodes the gamma chain isoform laminin, gamma 3. The gamma 3 chain is most similar to the gamma 1 chain, and contains all the 6 domains expected of the gamma chain. It is a component of laminin 12. The gamma 3 chain is broadly expressed in skin, heart, lung, and the reproductive tracts. In skin, it is seen within the basement membrane of the dermal-epidermal junction at points of nerve penetration. Gamma 3 is also a prominent element of the apical surface of ciliated epithelial cells of lung, oviduct, epididymis, ductus deferens, and seminiferous tubules. The distribution of gamma 3-containing laminins along ciliated epithelial surfaces suggests that the apical laminins are important in the morphogenesis and structural stability of the ciliated processes of these cells. [provided by RefSeq, Aug 2011]
LAMC3 Gene-Disease associations (from GenCC):
  • occipital pachygyria and polymicrogyria
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, G2P, Orphanet, Illumina
  • complex neurodevelopmental disorder
    Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0069152415).
BP6
Variant 9-131057028-C-T is Benign according to our data. Variant chr9-131057028-C-T is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 378068.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00776 (1182/152308) while in subpopulation AFR AF = 0.0259 (1076/41560). AF 95% confidence interval is 0.0246. There are 18 homozygotes in GnomAd4. There are 547 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 18 AR,AD gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
LAMC3NM_006059.4 linkc.2039C>T p.Thr680Met missense_variant Exon 12 of 28 ENST00000361069.9 NP_006050.3
LAMC3XM_011518121.2 linkc.2039C>T p.Thr680Met missense_variant Exon 12 of 28 XP_011516423.1
LAMC3XM_006716921.3 linkc.2039C>T p.Thr680Met missense_variant Exon 12 of 23 XP_006716984.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
LAMC3ENST00000361069.9 linkc.2039C>T p.Thr680Met missense_variant Exon 12 of 28 2 NM_006059.4 ENSP00000354360.4

Frequencies

GnomAD3 genomes
AF:
0.00775
AC:
1179
AN:
152190
Hom.:
18
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0259
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00262
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.000385
Gnomad SAS
AF:
0.000207
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000779
Gnomad OTH
AF:
0.00478
GnomAD2 exomes
AF:
0.00228
AC:
574
AN:
251264
AF XY:
0.00183
show subpopulations
Gnomad AFR exome
AF:
0.0259
Gnomad AMR exome
AF:
0.00156
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.0000544
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000766
Gnomad OTH exome
AF:
0.000977
GnomAD4 exome
AF:
0.00152
AC:
2217
AN:
1461740
Hom.:
12
Cov.:
33
AF XY:
0.00136
AC XY:
992
AN XY:
727180
show subpopulations
African (AFR)
AF:
0.0272
AC:
910
AN:
33480
American (AMR)
AF:
0.00145
AC:
65
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26136
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39700
South Asian (SAS)
AF:
0.000220
AC:
19
AN:
86254
European-Finnish (FIN)
AF:
0.0000375
AC:
2
AN:
53348
Middle Eastern (MID)
AF:
0.00156
AC:
9
AN:
5768
European-Non Finnish (NFE)
AF:
0.000942
AC:
1047
AN:
1111938
Other (OTH)
AF:
0.00273
AC:
165
AN:
60392
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.472
Heterozygous variant carriers
0
129
257
386
514
643
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
56
112
168
224
280
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00776
AC:
1182
AN:
152308
Hom.:
18
Cov.:
33
AF XY:
0.00734
AC XY:
547
AN XY:
74480
show subpopulations
African (AFR)
AF:
0.0259
AC:
1076
AN:
41560
American (AMR)
AF:
0.00261
AC:
40
AN:
15302
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.000386
AC:
2
AN:
5180
South Asian (SAS)
AF:
0.000207
AC:
1
AN:
4828
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10624
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.000779
AC:
53
AN:
68024
Other (OTH)
AF:
0.00473
AC:
10
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
56
112
169
225
281
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00361
Hom.:
13
Bravo
AF:
0.00904
TwinsUK
AF:
0.000809
AC:
3
ALSPAC
AF:
0.00104
AC:
4
ESP6500AA
AF:
0.0250
AC:
110
ESP6500EA
AF:
0.00128
AC:
11
ExAC
AF:
0.00271
AC:
329
Asia WGS
AF:
0.00260
AC:
9
AN:
3478
EpiCase
AF:
0.000654
EpiControl
AF:
0.000593

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:4
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Laboratory of Diagnostic Genome Analysis, Leiden University Medical Center (LUMC)
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

Feb 22, 2017
Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

not specified Benign:2
Jun 16, 2016
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease.

Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.072
BayesDel_addAF
Benign
-0.56
T
BayesDel_noAF
Benign
-0.56
CADD
Benign
3.6
DANN
Benign
0.96
DEOGEN2
Benign
0.052
T
Eigen
Benign
-0.96
Eigen_PC
Benign
-1.0
FATHMM_MKL
Benign
0.082
N
LIST_S2
Benign
0.23
T
MetaRNN
Benign
0.0069
T
MetaSVM
Benign
-0.98
T
MutationAssessor
Benign
1.5
L
PhyloP100
-2.9
PrimateAI
Benign
0.28
T
PROVEAN
Benign
-0.37
N
REVEL
Benign
0.043
Sift
Benign
0.18
T
Sift4G
Benign
0.12
T
Vest4
0.20
ClinPred
0.0055
T
GERP RS
-0.94
Varity_R
0.046
gMVP
0.33
Mutation Taster
=95/5
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs73658916; hg19: chr9-133932415; API